Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Trial details
- Registry ID
- NCT06906341
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersNCT06906341 | Corcept Therapeutics | Phase 2 | Recruiting | 2027-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |